CoChat

Multinational comparison of new antidepressant use in older adults: a cohort study

Open access
Tamblyn, Robyn, Bates, David Westfall, Buckeridge, David L, Dixon, Will, Forster, Alan J, Girard, Nadyne, Haas, Jennifer, Habib, Bettina, Kurteva, Siyana, Li, Jack, Sheppard, Therese · 2019 · BMJ Open
Cited by 76

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Abstract

Objectives: We used an international pharmacosurveillance network to estimate the rate and characteristics of antidepressant use in older adults in countries with more conservative (UK) and liberal depression guidelines (Canada, USA). Setting: Electronic health records and population-based administrative data from six jurisdictions in four countries (UK, Taiwan, USA and Canada). Participants: A historical cohort of older adults (≥65 years) who had a new episode of antidepressant use between 2009 and 2014. Outcome measures: The age and sex-standardised cumulative incidence of new episodes of antidepressant use in older adults was measured. Descriptive statistics were used to compare the proportion of new users by the antidepressant prescribed, therapeutic class, potential treatment indication and country, as well as the characteristics of the first treatment episode (standardised daily doses, duration and changes). Results: The incidence of antidepressant use between 2009 and 2014 varied from 4.7% (Montreal and Quebec City) to 18.6% (Taiwan). Tricyclic antidepressants (TCAs) were the most commonly used class in the UK (48.8%) and Taiwan (52.4%) compared with selective serotonin reuptake inhibitors (SSRIs) in North American jurisdictions (42.3%–53.3%). Chronic pain was the most common potential treatment indication (41.2%–68.2%). Among users with chronic pain, TCAs were used most frequently in the UK and Taiwan (55.2%–60.4%), whereas SSRIs were used most frequently in North America (33.5%–46.4%). Treatment was longer (252–525 vs 169–437 days), standardised doses were higher (0.7–1.3 vs 0.5–1.0) and treatment was more likely to be changed (31%–46% vs 21%–34%) among patients with depression (9.1%–43%) than those with chronic pain. Conclusion: Antidepressant use in older adults varied 24-fold by country, with the UK, which has the most conservative treatment guidelines, being among the lowest. Chronic pain was the most common potential treatment indication. Evaluation of real-world risks of TCAs is a priority for future research, given high rates of use and the potential for increased toxicity in older adults because of potent anticholinergic effects.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/bmjopen-2018-027663

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 13 references

Cited by

See all 76

Metadata

Authors
Tamblyn, R., Bates, D. W., Buckeridge, D. L., Dixon, W., Forster, A. J., Girard, N., Haas, J., Habib, B., Kurteva, S., Li, J., & Sheppard, T.
Venue
BMJ Open
Publisher
BMJ
Published
2019-05
Volume
9
Issue
5
Pages
e027663
ISSN
2044-6055 (ISSN-L)
OpenAlex
W2946715802
Cited by
76
References
13
FWCI
2.88
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Multinational comparison of new antidepressant use in older adults: a cohort study. https://app.cochat.ai/papers/10.1136/bmjopen-2018-027663
The paper
Tamblyn, R., Bates, D. W., Buckeridge, D. L., Dixon, W., Forster, A. J., Girard, N., Haas, J., Habib, B., Kurteva, S., Li, J., & Sheppard, T. (2019). Multinational comparison of new antidepressant use in older adults: a cohort study. BMJ Open. https://doi.org/10.1136/bmjopen-2018-027663

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.